Supriya Lifescience Ltd (SUPRIYA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "866.70",
    "chg": 6.7,
    "chgp": "0.78%",
    "dir": 1,
    "prev_price": "860.00",
    "mcapval": "6,953.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE07RO01027",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "15:32 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "1.88 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-buy-by-marketsmojo-4120319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_mojoScore_4120319.png",
        "date": "2026-07-25 10:10:04",
        "description": "Supriya Lifescience Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4104495",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4104495.png",
        "date": "2026-07-16 08:03:47",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. Despite a recent day decline of 2.04%, the stock’s technical indicators, including MACD, RSI, and moving averages, suggest a cautiously optimistic outlook amid mixed signals across weekly and monthly timeframes."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-4103167",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4103167.png",
        "date": "2026-07-15 08:05:00",
        "description": "Supriya Lifescience Ltd has demonstrated a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting renewed investor interest and potential upside in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-buy-4100865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_mojoScore_4100865.png",
        "date": "2026-07-14 10:10:04",
        "description": "Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4100071",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4100071.png",
        "date": "2026-07-14 08:06:20",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-4094490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4094490.png",
        "date": "2026-07-09 08:06:39",
        "description": "Supriya Lifescience Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. Following a recent upgrade from a Sell to a Buy rating, the pharmaceutical and biotechnology company is showing promising signs of price strength and positive market sentiment, supported by robust technical parameters and improving trend assessments."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-market-signals-4092914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4092914.png",
        "date": "2026-07-08 08:06:04",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a recent day decline of 2.78%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and market context to provide a comprehensive view for investors."
      },
      {
        "title": "Supriya Lifescience Ltd Sees Bullish Technical Shift Amid Price Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-sees-bullish-technical-shift-amid-price-volatility-4091517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_technicaldot_4091517.png",
        "date": "2026-07-07 08:07:48",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a sharp one-day decline of 11.62% to close at ₹865.75 on 7 Jul 2026, the underlying technical indicators suggest a strengthening positive outlook for this small-cap pharmaceutical and biotechnology stock."
      },
      {
        "title": "Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 6 July 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-low-amid-price-pressure-on-6-july-2026-4090764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SupriyaLifescie_priceRelatedfactors_4090764.png",
        "date": "2026-07-06 10:32:56",
        "description": "Supriya Lifescience Ltd experienced a notable decline today, touching an intraday low of Rs 894.25, reflecting a sharp price pressure of -8.71%. The stock underperformed its sector and broader market indices, continuing a recent trend of subdued performance amid mixed market sentiment."
      }
    ],
    "total": 360,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-Jul-2026",
      "details": "Please find attached copy of Newspaper Publication of Postal Ballot Notice.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "21-Jul-2026",
      "details": "Please Find Attached Postal Ballot Notice of Supriya Lifescience Limited.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jul-2026",
      "details": "Enclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 received from RTA.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd is Rated Buy by MarketsMOJO

2026-07-25 10:10:04

Supriya Lifescience Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-07-16 08:03:47

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. Despite a recent day decline of 2.04%, the stock’s technical indicators, including MACD, RSI, and moving averages, suggest a cautiously optimistic outlook amid mixed signals across weekly and monthly timeframes.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-15 08:05:00

Supriya Lifescience Ltd has demonstrated a significant shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by positive signals from key technical indicators such as MACD, moving averages, and Bollinger Bands, suggesting renewed investor interest and potential upside in the pharmaceuticals and biotechnology sector.

Read full news article

Supriya Lifescience Ltd is Rated Buy

2026-07-14 10:10:04

Supriya Lifescience Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-07-14 08:06:20

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-July 2026. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the pharmaceuticals and biotechnology sector.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-09 08:06:39

Supriya Lifescience Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. Following a recent upgrade from a Sell to a Buy rating, the pharmaceutical and biotechnology company is showing promising signs of price strength and positive market sentiment, supported by robust technical parameters and improving trend assessments.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-08 08:06:04

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late May 2026. Despite a recent day decline of 2.78%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and market context to provide a comprehensive view for investors.

Read full news article

Supriya Lifescience Ltd Sees Bullish Technical Shift Amid Price Volatility

2026-07-07 08:07:48

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a sharp one-day decline of 11.62% to close at ₹865.75 on 7 Jul 2026, the underlying technical indicators suggest a strengthening positive outlook for this small-cap pharmaceutical and biotechnology stock.

Read full news article

Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 6 July 2026

2026-07-06 10:32:56

Supriya Lifescience Ltd experienced a notable decline today, touching an intraday low of Rs 894.25, reflecting a sharp price pressure of -8.71%. The stock underperformed its sector and broader market indices, continuing a recent trend of subdued performance amid mixed market sentiment.

Read full news article

View All News